Wogonin Alleviates Aconitine-induced Gastric Tissue Damage in Gastric Cancer through PI3K/Akt Signaling Pathway

ABSTRACT

Background and Objectives: Aconitine is a toxic substance capable of causing damage to the nervous system, digestive system, and gastric tissue. Wogonin exhibits significant antibacterial, antioxidant, and potential anticancer effects. The PI3K/Akt pathway is known to engage in the development of cancer cells. Consequently, it is of great significance to investigate the potential of wogonin on aconitine-induced gastric tissue damage in gastric cancer (GC) and its correlation with the signaling pathway. Materials and Methods: Forty modelled mice were divided into a normal group, normal saline group, aconitine (low, high) dose group, wogonin (high, medium, low) dose group, celecoxib group, and Weifuchun group. After treatment, we detected the mouse’s tumor volume and survival day, as well as determined the expression of PI3K/Akt, LC3B, and p62. Results: During modeling, HE staining revealed that the low-dose aconitine group exhibited improved pathological conditions, reduced tumor volume and mass compared to the saline group, and elevated survival days. After modeling, tumor volume and mass decreased concentration-dependent in each wogonin dose group. Wogonin treatment greatly prolongs survival days and effectively inhibits tumor growth. The expressions of LC3B, P62, PI3K, Akt, and mTOR mRNA were all decreased compared to the model group. Meanwhile, the treatment promoted the expression of LC3 and Beclin1 proteins related to the autophagy pathway. Conclusion: Wogonin effectively ameliorates gastric tissue damage induced by aconitine in GC, prolongs the survival days of mice, and inhibits tumor growth through activation of the PI3K/Akt signaling pathway and reduction of P62 protein.

KEYWORDS

• Wogonin
• PI3K/Akt
• gastric cancer
• aconitine

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241296601Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 21, ISSUE 3Bioflavonoid Tangeretin regulates RANK/RANKL/OPG Signaling Proteins via Stimulating Estrogenic Activity in Ovariectomized RatsWeike Tian, Wei Zhang, Li Chen, Junlei Liao, Xuesong Yang · pp. 1001–1012Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3PhcogMag 21 3 1013Yanhong Zhang, Yanlong He · pp. 1013–1021Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3Rosmanol Effectively Prevents Diethylnitrosamine-induced Hepatocellular Carcinoma in Rats by Regulating the PI3K/Akt Signaling PathwayWei Cao, Qi Liu, Ying Wang, Lianfeng Chen · pp. 1022–1033Original Research ArticleSame type: Article
• Article · VOLUME 21, ISSUE 3Liquiritin Promotes Vasodilation Effects by Activating the Kv and KATP Channels in the Isolated Rat Thoracic AortaMengXue Ma, YouLan Che, Xin Yang, Zhi Wang, Ya Wen Bai, Yang Yu, QingBin Xu, Ru Zhou · pp. 1034–1042Original Research ArticleSame type: Article